ZyVersa Therapeutics Announces Equity Research Coverage Initiated by Noble Capital Markets
January 04, 2024 07:50 ET
|
ZyVersa Therapeutics
ZyVersa is developing two proprietary product platforms targeting renal and inflammatory diseases. Cholesterol Efflux MediatorTM VAR 200, designed to ameliorate renal lipid accumulation that...
ZyVersa Therapeutics to Participate in a Fireside Chat at Oppenheimer Healthcare Conference
March 01, 2023 09:20 ET
|
ZyVersa Therapeutics
CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease, and inflammasome ASC inhibitor IC 100 for...
ZyVersa Therapeutics to Participate in a Fireside Chat at Roth Annual Conference
February 27, 2023 09:20 ET
|
ZyVersa Therapeutics
CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease, and inflammasome ASC inhibitor IC 100 which...
Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients
September 14, 2022 09:00 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB: SIGY), a development-stage company focused on the creation of therapeutic solutions that address...
Peripheral Intravenous Catheters Market To Reach USD 7.52 Billion By 2027 | Reports and Data
March 04, 2020 12:00 ET
|
Reports and Data
New York, March 04, 2020 (GLOBE NEWSWIRE) -- The global Peripheral Intravenous Catheters market is forecast to reach USD 7.52 Billion by 2027, according to a new report by Reports and Data....
Nephros Announces $2.9 Million Private Placement
April 11, 2018 07:30 ET
|
Nephros, Inc.
SOUTH ORANGE, NJ, April 11, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters...
2017 Satellite Healthcare Norman S. Coplon Extramural Grant Program Now Accepting Applications
January 03, 2017 09:00 ET
|
Satellite Healthcare
SAN JOSE, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce that the Norman S. Coplon Extramural Grant Program...
CMS Five-Star Quality Rating System Identifies Satellite Healthcare as Leading 10 Largest Dialysis Providers in Percentage of Top-Rated Dialysis Centers
October 27, 2016 15:31 ET
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare today announced that it leads the industry with the highest percentage of top-rated dialysis centers among the 10 largest...
Satellite Healthcare Partners with American Kidney Fund to Support Clinical Research
August 15, 2016 09:00 ET
|
Satellite Healthcare
SAN JOSE, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce that it has joined forces with the American Kidney...
Satellite Healthcare Congratulates 2016 Coplon Grant Recipients
August 11, 2016 09:00 ET
|
Satellite Healthcare
SAN JOSE, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce the recipients of the 2016 Norman S. Coplon...